Superoxide dismutase (SOD1) gene variants may cause amyotrophic lateral sclerosis, some
of which are associated with a distinct phenotype. Most studies assess limited variants or …

The expansion of a hexanucleotide repeat GGGGCC in C9orf72 is the most common known
cause of ALS accounting for ~ 40% familial cases and ~ 7% sporadic cases in the European …

Amyotrophic lateral sclerosis (ALS) is a heterogeneous neurodegenerative syndrome. In up
to 20% of cases, a family history is observed. Although Mendelian disease gene variants are …

Introduction Amyotrophic lateral sclerosis (ALS) has a reported incidence of 1–2/100,000
person-years. It is estimated that there are 5000 people with ALS in the UK at any one time; …

There is a strong genetic contribution to Amyotrophic lateral sclerosis (ALS) risk, with heritability
estimates of up to 60%. Both Mendelian and small effect variants have been identified, …

We meta-analyze amyotrophic lateral sclerosis (ALS) genome-wide association study (GWAS)
data of European and Chinese populations (84,694 individuals). We find an additional …

Objective Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative
disease of motor neurons with a median survival of 2 years. Familial ALS has a younger age of …

Background Genetic penetrance is the probability of a phenotype when harbouring a
particular pathogenic variant. Accurate penetrance estimates are important across biomedical …

Introduction: Susceptibility to amyotrophic lateral sclerosis (ALS) is associated with smoking
in some studies, but it is not clear which aspect of smoking behavior is related. Using …

Objective Smoking has been widely studied as a susceptibility factor for amyotrophic lateral
sclerosis (ALS), but results are conflicting and at risk of confounding bias. We used the …